메페남산

메페남산
메페남산 구조식 이미지
카스 번호:
61-68-7
한글명:
메페남산
동의어(한글):
메페남산;2-((2,3-다이메틸페닐)아미노)벤조산;N-(2,3-디메틸페닐)엔트라닐산
상품명:
Mefenamic acid
동의어(영문):
Mefenamic;Mefanamic acid;MEFENAMATE;Ponstel;Ponstan;ac.mefenamico;Mephenamic acid;Mefenamic Acid (200 mg);in-M;HL 1
CBNumber:
CB5472051
분자식:
C15H15NO2
포뮬러 무게:
241.29
MOL 파일:
61-68-7.mol
MSDS 파일:
SDS

메페남산 속성

녹는점
230 °C
끓는 점
384.06°C (rough estimate)
밀도
1.0944 (rough estimate)
굴절률
1.5200 (estimate)
저장 조건
2-8°C
용해도
물에는 거의 녹지 않으며, 에탄올(96%)과 염화메틸렌에는 약간 녹습니다. 알칼리 수산화물의 묽은 용액에 용해됩니다.
물리적 상태
Solid
산도 계수 (pKa)
4.2(at 25℃)
색상
흰색에서 연한 노란색
수용성
아세톤, 클로로포름, 디클로로메탄, 메탄올에 용해됩니다. 물에 불용성.
Merck
14,5798
InChIKey
HYYBABOKPJLUIN-UHFFFAOYSA-N
LogP
5.120
CAS 데이터베이스
61-68-7(CAS DataBase Reference)
NIST
Mefenamic acid(61-68-7)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 Xn
위험 카페고리 넘버 22-40-20/21/22
안전지침서 22-36
WGK 독일 3
RTECS 번호 CB4550000
HS 번호 28142000
유해 물질 데이터 61-68-7(Hazardous Substances Data)
독성 LD50 orally in mice, rats: 630, 790 mg/kg (Jahn, Adrian)
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H302 삼키면 유해함 급성 독성 물질 - 경구 구분 4 경고 GHS hazard pictograms P264, P270, P301+P312, P330, P501
예방조치문구:
NFPA 704
0
2 0

메페남산 MSDS


2-[(2,3-Dimethylphenyl)amino]benzoic acid

메페남산 C화학적 특성, 용도, 생산

화학적 성질

white or light yellow crystalline powder, odorless, insoluble in water, slightly soluble in ethanol, chloroform, slightly soluble in ether. Melting point 230-231°C, mefenamic acid is an anti-inflammatory analgesic with antipyretic, analgesic and anti-inflammatory effects.

용도

Mefenamic acid is used for the same indications as flufenamic acid. Synonyms for this drug are parkemed, ponstan, ponstel, and others.

Indications

Mefenamic acid (Ponstel) is indicated only for analgesia and primary dysmenorrhea when therapy will not exceed 1 week.

정의

ChEBI: An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to b minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

일반 설명

Mefenamic acid (Ponstel, Ponstan) is one of the oldestNSAIDs, introduced into the market in 1967 for mild tomoderate pain and for primary dysmenorrhea. It is rapidly absorbed with peak plasma levels occurring 2 to 4 hoursafter oral administration. It undergoes hepatic benzylic hydroxylationof its 3'methyl group regioselectively into twoinactive metabolites, 3'-hydroxymethylmefenamic acid andthe 3'carboxylate metabolite (via further oxidation of thebenzylic alcohol group). The parent drugs and these metabolitesare conjugated with glucuronic acid and excreted primarilyin the urine. Thus, although patients with knownliver deficiency may be given lower doses, it is contraindicatedin patients with preexisting renal dysfunction.
Common side effects associated with its use include diarrhea,drowsiness, and headache. The possibility of blood disordershas also prompted limitation of its administration to 7days. It is not recommended for children or during pregnancy.

Clinical Use

Mefenamic acid is synthesized from o-chlorobenzoic acid and 2,3-dimethylaniline under catalytic conditions. Mefenamic acid is the only fenamic acid derivative that produces analgesia centrally and peripherally. Mefenamic acid is indicated for the short-term relief of moderate pain and for primary dysmenorrhea.

신진 대사

Mefenamic acid is absorbed rapidly following oral administration, with peak plasma levels being attained within 2 to 4 hours. It is highly bound to plasma proteins (78.5%) and has a plasma half-life of 2 to 4 hours. Metabolism occurs through regioselective oxidation of the 3′-methyl group and glucuronidation of mefenamic acid and its metabolites. Urinary excretion accounts for approximately 50 to 55% of an administered dose, with unchanged drug accounting for 6%, the 3′-hydroxymethyl metabolite (primarily as the glucuronide) accounting for 25%, and the remaining 20% as the dicarboxylic acid (of which 30% is the glucuronide conjugate). These metabolites are essentially inactive.

메페남산 준비 용품 및 원자재

원자재

준비 용품


메페남산 공급 업체

글로벌( 596)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Hebei Mojin Biotechnology Co., Ltd
+86 13288715578 +8613288715578
sales@hbmojin.com China 12840 58
Xiamen Wonderful Bio Technology Co., Ltd.
+8613043004613
Sara@xmwonderfulbio.com China 283 58
Anhui Ruihan Technology Co., Ltd
+8617756083858
daisy@anhuiruihan.com China 973 58
Sigma Audley
+86-15937194204 +86-18126314766
nova@sh-teruiop.com China 467 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618092446649
sarah@tnjone.com China 1143 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21634 55
Hefei TNJ Chemical Industry Co.,Ltd.
+86-0551-65418679 +8618949832763
info@tnjchem.com China 2986 55
Shanghai Zheyan Biotech Co., Ltd.
18017610038
zheyansh@163.com CHINA 3619 58
career henan chemical co
+86-0371-86658258 +8613203830695
sales@coreychem.com China 29884 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28172 58

메페남산 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved